(Q36630742)

English

Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial

scientific article published on 18 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

Fei Zhou

1

1 reference

Europe PubMed Central

15 August 2017

Ning Li

2

1 reference

Europe PubMed Central

15 August 2017

Weihua Jiang

3

1 reference

Europe PubMed Central

15 August 2017

Zhaolai Hua

4

1 reference

Europe PubMed Central

15 August 2017

Lin Xia

5

1 reference

Europe PubMed Central

15 August 2017

Qingyi Wei

6

1 reference

Europe PubMed Central

15 August 2017

Liwei Wang

7

1 reference

Europe PubMed Central

15 August 2017

publication date

18 December 2012

1 reference

Europe PubMed Central

15 August 2017

World Journal of Surgical Oncology

1 reference

Europe PubMed Central

15 August 2017

10

1 reference

Europe PubMed Central

15 August 2017

274

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1186/1477-7819-10-274

0 references

Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Her-2/neu and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Basic science of HER-2/neu: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

30 September 2017

Metastatic gastric cancer - focus on targeted therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

28 June 2018

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

28 June 2018

Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

20 September 2018

Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

20 September 2018

HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

20 September 2018

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

20 September 2018

HER-2 amplification is highly homogenous in gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579675

20 September 2018

[Estimation of cancer incidence and mortality in China in 2004-2005]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of C-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for C-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-transcriptional control of c-erb B-2 overexpression in stomach cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-cadherin mutations in gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23249720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1477-7819-10-274

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36630742&oldid=1642436935"